EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 9.09 Billion EUR | -11.18% |
| 2022 | 10.24 Billion EUR | 5.35% |
| 2021 | 9.72 Billion EUR | 202.74% |
| 2020 | 3.21 Billion EUR | -29.85% |
| 2019 | 4.57 Billion EUR | 136.27% |
| 2018 | 1.93 Billion EUR | 15.29% |
| 2017 | 1.68 Billion EUR | -19.68% |
| 2016 | 2.09 Billion EUR | -0.95% |
| 2015 | 2.11 Billion EUR | 16.04% |
| 2014 | 1.82 Billion EUR | 369.33% |
| 2013 | 388 Million EUR | 51.98% |
| 2012 | 255.29 Million EUR | -51.41% |
| 2011 | 525.41 Million EUR | 65.57% |
| 2010 | 317.33 Million EUR | 1655.79% |
| 2009 | -20.39 Million EUR | -114.08% |
| 2008 | 144.88 Million EUR | 163.42% |
| 2007 | -228.42 Million EUR | -69.36% |
| 2006 | -134.88 Million EUR | -127.26% |
| 2005 | 494.78 Million EUR | -8.16% |
| 2004 | 538.76 Million EUR | -12.26% |
| 2003 | 614.03 Million EUR | 74.16% |
| 2002 | 352.57 Million EUR | 2.66% |
| 2001 | 343.43 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 8.9 Billion EUR | -2.1% |
| 2024 Q2 | 6.24 Billion EUR | 9.54% |
| 2023 Q2 | 10.05 Billion EUR | 9.11% |
| 2023 Q1 | 9.21 Billion EUR | -10.01% |
| 2023 Q4 | 9.09 Billion EUR | 10.18% |
| 2023 Q3 | 8.25 Billion EUR | -17.9% |
| 2023 FY | 9.09 Billion EUR | -11.18% |
| 2022 Q3 | 9.39 Billion EUR | -10.0% |
| 2022 Q4 | 10.24 Billion EUR | 9.0% |
| 2022 Q1 | 9.58 Billion EUR | -1.47% |
| 2022 FY | 10.24 Billion EUR | 5.35% |
| 2022 Q2 | 10.44 Billion EUR | 8.99% |
| 2021 FY | 9.72 Billion EUR | 202.74% |
| 2021 Q1 | 1.49 Billion EUR | -53.52% |
| 2021 Q4 | 9.72 Billion EUR | 9.43% |
| 2021 Q2 | 1.98 Billion EUR | 33.22% |
| 2021 Q3 | 8.88 Billion EUR | 346.76% |
| 2020 FY | 3.21 Billion EUR | -29.85% |
| 2020 Q3 | 2.68 Billion EUR | -46.93% |
| 2020 Q1 | 4.46 Billion EUR | -2.4% |
| 2020 Q4 | 3.21 Billion EUR | 19.63% |
| 2020 Q2 | 5.05 Billion EUR | 13.2% |
| 2019 Q1 | 4.27 Billion EUR | 120.49% |
| 2019 FY | 4.57 Billion EUR | 136.27% |
| 2019 Q3 | 4.05 Billion EUR | -14.88% |
| 2019 Q4 | 4.57 Billion EUR | 13.06% |
| 2019 Q2 | 4.75 Billion EUR | 11.35% |
| 2018 Q2 | 1.97 Billion EUR | 0.0% |
| 2018 FY | 1.93 Billion EUR | 15.29% |
| 2018 Q4 | 1.93 Billion EUR | -42.87% |
| 2018 Q3 | 3.39 Billion EUR | 71.75% |
| 2018 Q1 | 1.97 Billion EUR | 17.49% |
| 2017 Q4 | 1.68 Billion EUR | 130.59% |
| 2017 Q3 | 729 Million EUR | -67.9% |
| 2017 Q2 | 2.27 Billion EUR | 0.0% |
| 2017 Q1 | 2.27 Billion EUR | 8.5% |
| 2017 FY | 1.68 Billion EUR | -19.68% |
| 2016 Q2 | 2.21 Billion EUR | 0.0% |
| 2016 FY | 2.09 Billion EUR | -0.95% |
| 2016 Q1 | 2.21 Billion EUR | 4.59% |
| 2016 Q3 | 2.09 Billion EUR | -5.43% |
| 2016 Q4 | 2.09 Billion EUR | 0.14% |
| 2015 Q3 | 2.1 Billion EUR | -3.57% |
| 2015 FY | 2.11 Billion EUR | 16.04% |
| 2015 Q2 | 2.18 Billion EUR | 0.0% |
| 2015 Q4 | 2.11 Billion EUR | 0.19% |
| 2015 Q1 | 2.18 Billion EUR | 20.1% |
| 2014 Q2 | 2.18 Billion EUR | 0.0% |
| 2014 FY | 1.82 Billion EUR | 369.33% |
| 2014 Q3 | 1.81 Billion EUR | -16.6% |
| 2014 Q4 | 1.82 Billion EUR | 0.11% |
| 2014 Q1 | 2.18 Billion EUR | 462.11% |
| 2013 Q1 | 430.82 Million EUR | 68.76% |
| 2013 Q4 | 388 Million EUR | 0.0% |
| 2013 Q3 | 388 Million EUR | -9.94% |
| 2013 Q2 | 430.82 Million EUR | 0.0% |
| 2013 FY | 388 Million EUR | 51.98% |
| 2012 Q4 | 255.29 Million EUR | 0.0% |
| 2012 Q2 | 612.33 Million EUR | 0.0% |
| 2012 FY | 255.29 Million EUR | -51.41% |
| 2011 FY | 525.41 Million EUR | 65.57% |
| 2011 Q2 | 480.3 Million EUR | 0.0% |
| 2011 Q4 | 525.41 Million EUR | 0.0% |
| 2010 Q2 | 642.9 Million EUR | 0.0% |
| 2010 FY | 317.33 Million EUR | 1655.79% |
| 2010 Q4 | 317.33 Million EUR | 0.0% |
| 2009 Q4 | -20.39 Million EUR | 0.0% |
| 2009 FY | -20.39 Million EUR | -114.08% |
| 2008 FY | 144.88 Million EUR | 163.42% |
| 2007 FY | -228.42 Million EUR | -69.36% |
| 2006 FY | -134.88 Million EUR | -127.26% |
| 2005 FY | 494.78 Million EUR | -8.16% |
| 2004 FY | 538.76 Million EUR | -12.26% |
| 2003 FY | 614.03 Million EUR | 74.16% |
| 2002 FY | 352.57 Million EUR | 2.66% |
| 2001 FY | 343.43 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -1896983.383% |
| Ansell Limited | -54.99 Million USD | 16644.578% |
| Ansell Limited | -55.1 Million USD | 16613.612% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 25033.435% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 8657404.333% |
| Psykey, Inc. | 634.59 Thousand USD | -1433732.393% |
| ConvaTec Group Plc | 1.2 Billion USD | -657.87% |
| ConvaTec Group Plc | 1.2 Billion USD | -656.799% |
| Encision Inc. | 1.29 Million USD | -704870.121% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -394015.0% |
| Innovative MedTech Inc. | 1.76 Million USD | -515501.2% |
| LifePoint, Inc. | -3.26 Million USD | 278866.589% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -185435.529% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -420760.315% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 21012015.758% |
| Reflect Scientific, Inc. | -1.03 Million USD | 878969.746% |
| SmileDirectClub, Inc. | 778.67 Million USD | -1068.52% |
| Sector 10, Inc. | 163 Thousand USD | -5582108.589% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 2279.118% |
| SheerVision, Inc. | 57.34 Thousand USD | -15865913.357% |
| United Health Products, Inc. | 660.56 Thousand USD | -1377348.836% |
| Vasamed, Inc. | 22.12 Thousand USD | -41130900.814% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -345709.3% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -1178101.142% |